Article Text
Guidelines for breast needle core biopsy handling and reporting in breast screening assessment
Abstract
Non-operative diagnosis has become the norm in breast disease assessment and, until relatively recently, fine needle aspiration cytology has been the sampling method of choice. The introduction of automated core biopsy guns in the mid 1990s led to the additional introduction of core biopsy in assessment units. This paper presents a summary of the guidance on handling and routine reporting of breast needle core biopsy specimens in the context of breast disease multidisciplinary assessment. This guidance has been produced by the UK National Coordinating Committee for Breast Screening Pathology and is endorsed by the European Commission working group on breast screening pathology.
- ADH, atypical ductal hyperplasia
- DCIS, ductal carcinoma in situ
- ER, oestrogen receptor
- FNAC, fine needle aspiration cytology
- NCCBSP, National Coordinating Committee for Breast Cancer Screening Pathology
- NHSBSP, National Health Service Breast Screening Programme
- WBN, needle core biopsy
- breast cancer
- guidelines
- needle biopsy
- pathology reporting
Statistics from Altmetric.com
Guidelines for breast needle core biopsy handling and reporting in breast screening assessment
Footnotes
-
The authors are members of the non-operative diagnosis subgroup of the UK National Coordinating Committee for Breast Screening Pathology UK. This manuscript has been prepared on behalf of members of the UK National Coordinating Committee for Breast Screening Pathology and the European Commission working group on breast screening pathology.